Immunization equity
- PMID: 26615172
- DOI: 10.1016/j.vaccine.2015.09.033
Immunization equity
Abstract
Health inequities are the unjust differences in health among different social groups. Unfortunately, inequities are the norm, both in terms of health status and access to, and use of, health services. Childhood immunizations reduce the incidence of vaccine-preventable diseases and represent a cost-effective way to foster health equity. This paper reflects a 2015 review of data from surveys conducted in developing countries from 2005 to 2011 that show significant inequities in immunization coverage and discusses several initiatives currently underway (including Gavi, the Vaccine Alliance) that are directed at increasing childhood immunizations or reducing or abolishing overall health inequities. These initiatives have already had a significant impact on disease burden and childhood mortality and give rise to optimism that health disparities may further be reduced and health equity achieved as a result of investments made in immunization.
Copyright © 2015 American Journal of Preventive Medicine and Elsevier Ltd. Published by Elsevier Ltd.. All rights reserved.
Similar articles
-
Immunization Equity.Am J Prev Med. 2015 Dec;49(6 Suppl 4):S399-405. doi: 10.1016/j.amepre.2015.04.018. Epub 2015 Aug 15. Am J Prev Med. 2015. PMID: 26282089
-
Charting the evolution of approaches employed by the Global Alliance for Vaccines and Immunizations (GAVI) to address inequities in access to immunization: a systematic qualitative review of GAVI policies, strategies and resource allocation mechanisms through an equity lens (1999-2014).BMC Public Health. 2015 Nov 30;15:1198. doi: 10.1186/s12889-015-2521-8. BMC Public Health. 2015. PMID: 26621528 Free PMC article.
-
Distributional impact of rotavirus vaccination in 25 GAVI countries: estimating disparities in benefits and cost-effectiveness.Vaccine. 2012 Apr 27;30 Suppl 1:A15-23. doi: 10.1016/j.vaccine.2012.01.018. Vaccine. 2012. PMID: 22520124
-
Vaccines, global health and social equity.Immunol Cell Biol. 2009 May-Jun;87(4):274-8. doi: 10.1038/icb.2009.15. Epub 2009 Mar 24. Immunol Cell Biol. 2009. PMID: 19308074 Review.
-
New vaccine introduction in the East and Southern African sub-region of the WHO African region in the context of GIVS and MDGs.Vaccine. 2012 Sep 7;30 Suppl 3:C3-8. doi: 10.1016/j.vaccine.2012.05.086. Vaccine. 2012. PMID: 22939018 Review.
Cited by
-
Impact of Vaccines; Health, Economic and Social Perspectives.Front Microbiol. 2020 Jul 14;11:1526. doi: 10.3389/fmicb.2020.01526. eCollection 2020. Front Microbiol. 2020. PMID: 32760367 Free PMC article. Review.
-
Optimal global spending for group A Streptococcus vaccine research and development.NPJ Vaccines. 2023 Apr 25;8(1):62. doi: 10.1038/s41541-023-00646-6. NPJ Vaccines. 2023. PMID: 37185380 Free PMC article.
-
Hesitancy in the time of coronavirus: Temporal, spatial, and sociodemographic variations in COVID-19 vaccine hesitancy.SSM Popul Health. 2021 Sep;15:100896. doi: 10.1016/j.ssmph.2021.100896. Epub 2021 Aug 13. SSM Popul Health. 2021. PMID: 34414255 Free PMC article.
-
Coverage and timeliness of vaccination and the validity of routine estimates: Insights from a vaccine registry in Kenya.Vaccine. 2018 Dec 18;36(52):7965-7974. doi: 10.1016/j.vaccine.2018.11.005. Epub 2018 Nov 8. Vaccine. 2018. PMID: 30416017 Free PMC article.
-
Madagascar's EPI vaccine programs: A systematic review uncovering the role of a child's sex and other barriers to vaccination.Front Public Health. 2022 Sep 16;10:995788. doi: 10.3389/fpubh.2022.995788. eCollection 2022. Front Public Health. 2022. PMID: 36187658 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical